Related Experiment Video
Updated: Feb 12, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ
Johana Hrdinová1, Fabian C Verbij1, Paul H P Kaijen1
1Department of Plasma Proteins, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, the Netherlands.
Abstract:
Formation of microthrombi is a hallmark of acquired thrombotic thrombocytopenic purpura. These microthrombi originate from insufficient processing of ultra large von Willebrand factor multimers by ADAMTS13 due to the development of anti-ADAMTS13 autoantibodies. Several studies have identified the major histocompatibility complex class II alleles HLA-DRB1*11, HLA-DQB1*03 and HLA-DQB1*02:02 as risk factors for acquired thrombotic thrombocytopenic purpura development. Previous research in our department indicated that ADAMTS13 CUB2 domain-derived peptides FINVAPHAR and LIRDTHSLR are presented on HLA-DRB1*11 and HLA-DRB1*03, respectively. Here, we describe the repertoire of ADAMTS13 peptides presented on HLA-DQ. In parallel, the repertoire of ADAMTS13-derived peptides presented on HLA-DR was monitored. Using HLA-DR- and HLA-DQ-specific antibodies, we purified HLA/peptide complexes from ADAMTS13-pulsed monocyte-derived dendritic cells. Using this approach, we identified ADAMTS13-derived peptides presented on HLA-DR for all 9 samples analyzed; ADAMTS13-derived peptides presented on HLA-DQ were identified in 4 out of 9 samples. We were able to confirm the presentation of the CUB2 domain-derived peptides FINVAPHAR and LIRDTHSLR on HLA-DR. In total, 12 different core-peptide sequences were identified on HLA-DR and 8 on HLA-DQ. For HLA-DR11, several potential new core-peptides were found; 4 novel core-peptides were exclusively identified on HLA-DQ. Furthermore, an in silico analysis was performed using the EpiMatrix and JanusMatrix tools to evaluate the eluted peptides, in the context of HLA-DR, for putative effector or regulatory T-cell responses at the population level. The results from this study provide a basis for the identification of immuno-dominant epitopes on ADAMTS13 involved in the onset of acquired thrombotic thrombocytopenic purpura.
Insights
Researchers identified specific ADAMTS13 protein fragments presented by HLA-DQ molecules, offering new insights into acquired thrombotic thrombocytopenic purpura (TTP) pathogenesis. This study maps TTP-associated ADAMTS13 epitopes, crucial for understanding TTP development.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Acquired thrombotic thrombocytopenic purpura (TTP) is characterized by microthrombi formation due to autoantibodies against ADAMTS13, leading to insufficient processing of ultra-large von Willebrand factor multimers.
- Major histocompatibility complex (MHC) class II alleles, including HLA-DRB1*11, HLA-DQB1*03, and HLA-DQB1*02:02, are identified risk factors for TTP development.
- Previous work identified ADAMTS13 CUB2 domain peptides presented on HLA-DRB1*11 and HLA-DRB1*03, but the repertoire presented on HLA-DQ remained largely uncharacterized.
Purpose of the Study:
- To characterize the repertoire of ADAMTS13-derived peptides presented on HLA-DQ molecules.
- To further investigate ADAMTS13 peptides presented on HLA-DR molecules.
- To identify potential T-cell epitopes involved in the pathogenesis of acquired TTP.
Main Methods:
- Purification of HLA/peptide complexes from ADAMTS13-pulsed monocyte-derived dendritic cells using HLA-DR- and HLA-DQ-specific antibodies.
- Identification of eluted ADAMTS13-derived peptides using mass spectrometry.
- In silico analysis of identified peptides for potential T-cell responses using EpiMatrix and JanusMatrix tools.
Main Results:
- ADAMTS13-derived peptides were identified on HLA-DR in all 9 samples and on HLA-DQ in 4 out of 9 samples.
- Previously identified CUB2 domain peptides (FINVAPHAR and LIRDTHSLR) were confirmed on HLA-DR.
- A total of 12 unique core-peptide sequences were identified on HLA-DR and 8 on HLA-DQ, including 4 novel core-peptides exclusively found on HLA-DQ.
Conclusions:
- This study elucidates the repertoire of ADAMTS13 peptides presented by HLA-DQ molecules, expanding our understanding of TTP immunopathogenesis.
- The identification of novel HLA-DQ-presented ADAMTS13 epitopes provides a basis for further investigation into TTP-specific T-cell responses.
- These findings contribute to identifying immuno-dominant epitopes on ADAMTS13, crucial for understanding the mechanisms underlying acquired TTP.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
09:32Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
Related Concept Videos
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Mass Spectrometry: Overview
Tandem Mass Spectrometry
Mass Spectrometry of Amines
Mass Spectrometry: Isotope Effect
Chemical Ionization (CI) Mass Spectrometry